3DMedcare

Biotechnology ResearchCalifornia, United States51-200 Employees

3DMedcare began as 3D Medicines in 2010 and operates in the biotechnology research sector with a focus on precision medicine in China. It applies automated molecular testing and AI-driven interpretation of genetic information to support early and personalized diagnosis. The company’s clinical laboratory is CAP-accredited and CLIA-certified to perform clinical testing across diverse disease areas, and it is based in Fremont, California, reflecting its cross-border presence. Its development portfolio includes AI-enabled genome interpretation and automated sequencing workflows, alongside RT-qPCR-based tests for SARS-CoV-2 introduced in response to the COVID-19 outbreak. Its customers include physicians and clinical laboratories seeking rapid, objective genomic insights to inform treatment decisions and infectious disease testing. A recent development is a license agreement to develop and commercialize YBL-013 in Greater China with Y-Biologics, illustrating ongoing collaboration to advance new therapeutics or diagnostics in the region.

Sign up for free to view info

Email Format Employee directory